A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)



Status:Terminated
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - 76
Updated:4/21/2016
Start Date:October 2013
End Date:December 2014

Use our guide to learn which trials are right for you!

This is a Phase 3b, multicenter study of the efficacy of golimumab 2 mg/kg IV in subjects
with active rheumatoid arthritis who are receiving methotrexate and have inadequate disease
control (defined as an erythrocyte sedimentation rate [ESR]-based Disease Activity Score in
28 joints [DAS28] ≥ 3.2 and ≥ 4 swollen and ≥ 4 tender joints) despite current anti-TNFα
therapy with infliximab 2 - 4 mg/kg every 4 weeks, 2 - 5 mg/kg every 5 weeks, 3 - 6 mg/kg
every 6 weeks, 3 - 7mg/kg every 7 weeks, or 4 - 8 mg/kg every 8 weeks.

To be eligible for participation, subjects must have previously demonstrated initial and/or
temporary improvement in disease signs and symptoms, who have since exhibited a diminished
response despite continued treatment. It is estimated that 200 subjects will be enrolled in
the study at approximately 85 global sites.

The study employs an open-label "active switch" design that moves subjects from infliximab
to golimumab 2 mg/kg IV. In general, subjects eligible for the study include men or women
who are currently receiving infliximab in actual clinical practice who are at least 18 years
of age with active rheumatoid arthritis, and have previously demonstrated initial and/or
temporary improvement in disease signs and symptoms, but now exhibit a diminished response
and inadequate disease control despite continued treatment. Subjects must have received
infliximab in combination with methotrexate for a minimum of 9 months prior to the first
screening visit.

The screening visit will occur sometime between Week -12 and Week -10. Consenting subjects
who meet screening criteria will receive their final dose of infliximab at Week -8 as part
of actual clinical practice. Golimumab IV treatment, which will be supplied by the sponsor,
will be received at Weeks 0, 4, 12, 20, and 28. The primary endpoint is at Week 24, the
final efficacy assessment is at Week 32, and a follow-up safety assessment by telephone is
at Week 44. There will be a maximum of 36 weeks between the last infliximab infusion at Week
-8 and the last infusion of golimumab at Week 28. The duration of study participation is
expected to be a maximum of 56 weeks (including the Screening Period, 32 weeks of golimumab
treatment and assessment, and a 12-week safety follow-up).

Major Inclusion Criteria include (but not limited to):

- Have a diagnosis of Rheumatoid Arthritis (according to the revised 1987 criteria of
the American Rheumatism Association).

- Treatment with infliximab and methotrexate for >= 9 months, (with stable doses of
methotrexate over last 16 weeks of 7.5 mg/week to 25 mg/week) and (anti-TNFα therapy
with infliximab 2 - 4 mg/kg every 4 weeks, 2 - 5 mg/kg every 5 weeks, 3 - 6 mg/kg
every 6 weeks, 3 - 7mg/kg every 7 weeks, or 4 - 8 mg/kg every 8 weeks).

- Disease Activity Score 28 (DAS28) ≥ 3.2 based on Erythrocyte Sedimentation Rate (ESR)
at Week -8 and Week 0.

- Swollen joint count (SJC) ≥ 4 and tender joint count (TJC) ≥ 4 at Week - 8 and at
Week 0.

- Prior response confirmed by physician.

Major Exclusion Criteria include (but not limited to):

- Have a history of latent or active granulomatous infection, including histoplasmosis,
or Have a history of latent or active granulomatous infection, including
histoplasmosis, or coccidioidomycosis, prior to the first screening visit or during
the Screening Period.

- Have had a Bacille Calmette-Guérin (BCG) vaccination within 12 months of screening.

- Have a chest radiograph within 3 months prior to the first administration of study
agent that shows an abnormality suggestive of a malignancy or current active
infection, including tuberculosis (TB), histoplasmosis, or coccidioidomycosis.

- Have previously received more than 1 of the currently approved subcutaneous (SC)
administered anti-TNFα agents, etanercept, certolizumab pegol, golimumab, or
adalimumab.

- Are pregnant, nursing, or planning a pregnancy or fathering a child within 6 months
after receiving the last administration of the study agent.

- Weight less than 35 kg or greater than 110 kg (less than 77 pounds or greater than
242 pounds).
We found this trial at
55
sites
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
?
mi
from
Arlington, VA
Click here to add this to my saved trials
?
mi
from
Asheville, NC
Click here to add this to my saved trials
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
?
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Charleston, South Carolina 29412
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
?
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
?
mi
from
Columbia, SC
Click here to add this to my saved trials
?
mi
from
Dayton, OH
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
?
mi
from
Duncansville, PA
Click here to add this to my saved trials
?
mi
from
Eagan, MN
Click here to add this to my saved trials
?
mi
from
Edina, MN
Click here to add this to my saved trials
?
mi
from
Fort Smith, AR
Click here to add this to my saved trials
?
mi
from
Fremont, CA
Click here to add this to my saved trials
?
mi
from
Fullerton, CA
Click here to add this to my saved trials
?
mi
from
Glendale, WI
Click here to add this to my saved trials
Greensboro, North Carolina 27401
?
mi
from
Greensboro, NC
Click here to add this to my saved trials
?
mi
from
Hickory, NC
Click here to add this to my saved trials
?
mi
from
Hixson, TN
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Huntsville, AL
Click here to add this to my saved trials
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
?
mi
from
Jakson, TN
Click here to add this to my saved trials
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
Myrtle Beach, South Carolina 29572
?
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
Orchard Park, NY
Click here to add this to my saved trials
?
mi
from
Orlando, FL
Click here to add this to my saved trials
?
mi
from
Peoria, AZ
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Plano, TX
Click here to add this to my saved trials
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
Santa Maria, CA
Click here to add this to my saved trials
?
mi
from
Sarasota, FL
Click here to add this to my saved trials
?
mi
from
South Bend, IN
Click here to add this to my saved trials
?
mi
from
Spokane, WA
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Thousand Oaks, California 91360
?
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
?
mi
from
Victoria,
Click here to add this to my saved trials
?
mi
from
Whittier, CA
Click here to add this to my saved trials
Wilmington, North Carolina 28401
?
mi
from
Wilmington, NC
Click here to add this to my saved trials
Wilmington, North Carolina 28401
?
mi
from
Wilmington, NC
Click here to add this to my saved trials
?
mi
from
Wyomissing, PA
Click here to add this to my saved trials